Press Releases

/Press Releases

Oramed to be Added to Russell Microcap® Index

NEW YORK, June 19, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc.(NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will be added to the FTSE Russell Microcap® Index effective at the open of market [...]

2018-06-19T08:25:00+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Conferences in May

NEW YORK, May 7, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it will present at three conferences over the next two weeks. DG Disruptive Growth [...]

2018-05-07T08:25:45+00:00 Categories: Press Releases|Tags: |

Oramed to Present at Oppenheimer’s Annual Healthcare Conference

NEW YORK, March 15, 2018 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ/TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that the Company will participate in the upcoming Oppenheimer's 28th Annual Healthcare Conference, being held March 20-21, 2018 [...]

2018-05-30T17:03:58+00:00 Categories: Press Releases|Tags: |

Oramed Adds Two New Members to its Scientific Advisory Board

NEW YORK, Feb. 28, 2018  /PRNewswire/ -- Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today the additions of Drs. Robert Henry and Jane Reusch to its Scientific Advisory Board. Dr. [...]

2018-05-30T17:03:59+00:00 Categories: Press Releases|Tags: |